Novel patterns of genome rearrangement and their association with survival in breast cancer
- PMID: 17142309
- PMCID: PMC1665631
- DOI: 10.1101/gr.5460106
Novel patterns of genome rearrangement and their association with survival in breast cancer
Abstract
Representational Oligonucleotide Microarray Analysis (ROMA) detects genomic amplifications and deletions with boundaries defined at a resolution of approximately 50 kb. We have used this technique to examine 243 breast tumors from two separate studies for which detailed clinical data were available. The very high resolution of this technology has enabled us to identify three characteristic patterns of genomic copy number variation in diploid tumors and to measure correlations with patient survival. One of these patterns is characterized by multiple closely spaced amplicons, or "firestorms," limited to single chromosome arms. These multiple amplifications are highly correlated with aggressive disease and poor survival even when the rest of the genome is relatively quiet. Analysis of a selected subset of clinical material suggests that a simple genomic calculation, based on the number and proximity of genomic alterations, correlates with life-table estimates of the probability of overall survival in patients with primary breast cancer. Based on this sample, we generate the working hypothesis that copy number profiling might provide information useful in making clinical decisions, especially regarding the use or not of systemic therapies (hormonal therapy, chemotherapy), in the management of operable primary breast cancer with ostensibly good prognosis, for example, small, node-negative, hormone-receptor-positive diploid cases.
Figures
References
-
- Ahr A., Karn T., Solbach C., Seiter T., Strebhardt K., Holtrich U., Kaufmann M., Karn T., Solbach C., Seiter T., Strebhardt K., Holtrich U., Kaufmann M., Solbach C., Seiter T., Strebhardt K., Holtrich U., Kaufmann M., Seiter T., Strebhardt K., Holtrich U., Kaufmann M., Strebhardt K., Holtrich U., Kaufmann M., Holtrich U., Kaufmann M., Kaufmann M. Identification of high risk breast-cancer patients by gene expression profiling. Lancet. 2002;359:131–132. - PubMed
-
- Albertson D.G. Profiling breast cancer by array CGH. Breast Cancer Res. Treat. 2003;78:289–298. - PubMed
-
- Al Kuraya K., Schraml P., Torhorst J., Tapia C., Zaharieva B., Novotny H., Spichtin H., Maurer R., Mirlacher M., Kochli O., Schraml P., Torhorst J., Tapia C., Zaharieva B., Novotny H., Spichtin H., Maurer R., Mirlacher M., Kochli O., Torhorst J., Tapia C., Zaharieva B., Novotny H., Spichtin H., Maurer R., Mirlacher M., Kochli O., Tapia C., Zaharieva B., Novotny H., Spichtin H., Maurer R., Mirlacher M., Kochli O., Zaharieva B., Novotny H., Spichtin H., Maurer R., Mirlacher M., Kochli O., Novotny H., Spichtin H., Maurer R., Mirlacher M., Kochli O., Spichtin H., Maurer R., Mirlacher M., Kochli O., Maurer R., Mirlacher M., Kochli O., Mirlacher M., Kochli O., Kochli O., et al. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res. 2004;64:8534–8540. - PubMed
-
- Balmain A., Gray J., Ponder B., Gray J., Ponder B., Ponder B. The genetics and genomics of cancer. Nat. Genet. 2003;33:238–244. - PubMed
-
- Berns E.M., de Klein A., van Putten W.L., van Staveren I.L., Bootsma A., Klijn J.G., Foekens J.A., de Klein A., van Putten W.L., van Staveren I.L., Bootsma A., Klijn J.G., Foekens J.A., van Putten W.L., van Staveren I.L., Bootsma A., Klijn J.G., Foekens J.A., van Staveren I.L., Bootsma A., Klijn J.G., Foekens J.A., Bootsma A., Klijn J.G., Foekens J.A., Klijn J.G., Foekens J.A., Foekens J.A. Association between RB-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival. Int. J. Cancer. 1995;64:140–145. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical